84 related articles for article (PubMed ID: 16037826)
21. Heat shock protein 27 expression in areca quid chewing-associated oral squamous cell carcinomas.
Lee SS; Tsai CH; Ho YC; Yu CC; Chang YC
Oral Dis; 2012 Oct; 18(7):713-9. PubMed ID: 22490108
[TBL] [Abstract][Full Text] [Related]
22. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
[TBL] [Abstract][Full Text] [Related]
23. Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression.
Chiang WC; Wong YK; Lin SC; Chang KW; Liu CJ
Oral Dis; 2006 Jan; 12(1):27-33. PubMed ID: 16390465
[TBL] [Abstract][Full Text] [Related]
24. Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer.
Lin CW; Tseng SW; Yang SF; Ko CP; Lin CH; Wei LH; Chien MH; Hsieh YS
Oral Dis; 2012 Nov; 18(8):734-40. PubMed ID: 22533572
[TBL] [Abstract][Full Text] [Related]
25. Metalloproteinase expression in normal and malignant oral keratinocytes: stimulation of MMP-2 and -9 by scatter factor.
Bennett JH; Morgan MJ; Whawell SA; Atkin P; Roblin P; Furness J; Speight PM
Eur J Oral Sci; 2000 Aug; 108(4):281-91. PubMed ID: 10946762
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer.
Jordan RC; Macabeo-Ong M; Shiboski CH; Dekker N; Ginzinger DG; Wong DT; Schmidt BL
Clin Cancer Res; 2004 Oct; 10(19):6460-5. PubMed ID: 15475433
[TBL] [Abstract][Full Text] [Related]
27. Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis.
Shieh TM; Lin SC; Liu CJ; Chang SS; Ku TH; Chang KW
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4378-85. PubMed ID: 17671119
[TBL] [Abstract][Full Text] [Related]
28. Oral and IV dosages of doxorubicin-methotrexate loaded- nanoparticles inhibit progression of oral cancer by down- regulation of matrix Methaloproteinase 2 expression in vivo.
Abbasi MM; Jahanban-Esfahlan R; Monfaredan A; Seidi K; Hamishehkar H; Khiavi MM
Asian Pac J Cancer Prev; 2014; 15(24):10705-11. PubMed ID: 25605162
[TBL] [Abstract][Full Text] [Related]
29. Activity of matrix metalloproteinase-2 (MMP-2) in canine oronasal tumors.
Nakaichi M; Yunuki T; Okuda M; Une S; Taura Y
Res Vet Sci; 2007 Apr; 82(2):271-9. PubMed ID: 17011604
[TBL] [Abstract][Full Text] [Related]
30. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
31. Serum and Saliva MMP-3 in Patients with OLP and Oral SCC.
Agha-Hosseini F; Mirzaii-Dizgah I; Mahboobi N; Shirazian S; Harirchi I
J Contemp Dent Pract; 2015 Feb; 16(2):107-11. PubMed ID: 25906800
[TBL] [Abstract][Full Text] [Related]
32. Arecoline N-Oxide Upregulates Caspase-8 Expression in Oral Hyperplastic Lesions of Mice.
Chang PY; Kuo TM; Chen PK; Lin YZ; Hua CH; Chen YC; Ko YC
J Agric Food Chem; 2017 Nov; 65(47):10197-10205. PubMed ID: 29092399
[TBL] [Abstract][Full Text] [Related]
33. Participation of fibroblasts in MMP-2 binding and activation on the surface of oral squamous cell carcinoma cells.
Hayashido Y; Urabe K; Yoshioka Y; Kitano H; Okamoto T; Matsuya T
Int J Oncol; 2003 Mar; 22(3):657-62. PubMed ID: 12579321
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
[TBL] [Abstract][Full Text] [Related]
35. High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.
Hsin CH; Chen MK; Tang CH; Lin HP; Chou MY; Lin CW; Yang SF
PLoS One; 2014; 9(11):e113129. PubMed ID: 25423087
[TBL] [Abstract][Full Text] [Related]
36. Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro.
Sundelin K; Roberg K; Grénman R; Håkansson L
Acta Otolaryngol; 2005 Jul; 125(7):765-73. PubMed ID: 16012040
[TBL] [Abstract][Full Text] [Related]
37. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
[TBL] [Abstract][Full Text] [Related]
38. Hydroxyl radical formation and oxidative DNA damage induced by areca quid in vivo.
Chen CL; Chi CW; Liu TY
J Toxicol Environ Health A; 2002 Feb; 65(3-4):327-36. PubMed ID: 11911495
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinase 20-dentin sialophosphoprotein interaction in oral cancer.
Saxena G; Koli K; de la Garza J; Ogbureke KU
J Dent Res; 2015 Apr; 94(4):584-93. PubMed ID: 25666817
[TBL] [Abstract][Full Text] [Related]
40. Alpha v beta 6 integrin down-regulates the MMP-13 expression in oral squamous cell carcinoma cells.
Ylipalosaari M; Thomas GJ; Nystrom M; Salhimi S; Marshall JF; Huotari V; Tervahartiala T; Sorsa T; Salo T
Exp Cell Res; 2005 Oct; 309(2):273-83. PubMed ID: 16024014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
